Julie Lapointe

468 total citations
27 papers, 266 citations indexed

About

Julie Lapointe is a scholar working on Genetics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julie Lapointe has authored 27 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 7 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julie Lapointe's work include BRCA gene mutations in cancer (15 papers), Global Cancer Incidence and Screening (7 papers) and Family Support in Illness (4 papers). Julie Lapointe is often cited by papers focused on BRCA gene mutations in cancer (15 papers), Global Cancer Incidence and Screening (7 papers) and Family Support in Illness (4 papers). Julie Lapointe collaborates with scholars based in Canada, United Kingdom and United States. Julie Lapointe's co-authors include Sylvie Montreuil, Clermont E. Dionne, Chantal Brisson, Paul Harasymowycz, Ali Salimi, Michel Dorval, Jacques Simard, Hermann Nabi, Nora Pashayan and Marc Germain and has published in prestigious journals such as BMJ Open, Psycho-Oncology and Cancers.

In The Last Decade

Julie Lapointe

25 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Lapointe Canada 10 62 55 54 49 48 27 266
Silke Zachariae Germany 9 101 1.6× 6 0.1× 7 0.1× 8 0.2× 60 1.3× 17 364
Alice Kennedy United States 8 20 0.3× 5 0.1× 30 0.6× 18 0.4× 53 1.1× 15 371
Daniel A. Bowen United States 11 3 0.0× 37 0.7× 7 0.1× 13 0.3× 28 0.6× 25 329
Heather Jackson United States 11 14 0.2× 6 0.1× 290 5.4× 103 2.1× 83 1.7× 37 478
J. Wallace United States 7 20 0.3× 8 0.1× 7 0.1× 13 0.3× 26 0.5× 13 326
Gabriela Villanueva United States 9 5 0.1× 22 0.4× 82 1.5× 17 0.3× 33 0.7× 20 230
Anna Yermachenko France 9 42 0.7× 6 0.1× 19 0.4× 3 0.1× 21 0.4× 13 345
Ingrid Solano United States 6 7 0.1× 15 0.3× 2 0.0× 16 0.3× 35 0.7× 8 462
Senthil Rajasekaran United States 7 5 0.1× 6 0.1× 17 0.3× 26 0.5× 122 2.5× 24 469
Faith A. Birnbaum United States 9 4 0.1× 6 0.1× 141 2.6× 76 1.6× 106 2.2× 22 347

Countries citing papers authored by Julie Lapointe

Since Specialization
Citations

This map shows the geographic impact of Julie Lapointe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Lapointe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Lapointe more than expected).

Fields of papers citing papers by Julie Lapointe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Lapointe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Lapointe. The network helps show where Julie Lapointe may publish in the future.

Co-authorship network of co-authors of Julie Lapointe

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Lapointe. A scholar is included among the top collaborators of Julie Lapointe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Lapointe. Julie Lapointe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guertin, Jason R., Michel Dorval, Julie Lapointe, et al.. (2024). Mapping inter-professional collaboration in oncogenetics: Results from a scoping review. Critical Reviews in Oncology/Hematology. 199. 104364–104364.
2.
Joly, Yann, et al.. (2024). General Medical Practitioners Acting as Geneticists, a Risky Business?. Érudit (Université de Montréal). 28(1). 152–171. 1 indexed citations
3.
Lapointe, Julie, et al.. (2023). Risk-stratified breast cancer screening incorporating a polygenic risk score: a survey of UK GPs’ knowledge and attitudes. British Journal of General Practice. 73(suppl 1). bjgp23X734157–bjgp23X734157. 1 indexed citations
4.
5.
Lapointe, Julie, Michel Dorval, Nora Pashayan, et al.. (2023). Canadian Healthcare Professionals’ Views and Attitudes toward Risk-Stratified Breast Cancer Screening. Journal of Personalized Medicine. 13(7). 1027–1027. 4 indexed citations
6.
7.
Guertin, Jason R., et al.. (2022). Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol. BMJ Open. 12(12). e066802–e066802. 1 indexed citations
8.
Lapointe, Julie, et al.. (2022). Scope of coverage of medical genetics and genomics in pre‐clerkship programs of Canadian faculties of medicine: A curriculum analysis. American Journal of Medical Genetics Part A. 191(1). 13–21. 2 indexed citations
9.
Lapointe, Julie, et al.. (2022). Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges. Critical Reviews in Oncology/Hematology. 178. 103797–103797. 3 indexed citations
10.
Lapointe, Julie, Michel Dorval, Nora Pashayan, et al.. (2022). Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals. Genetics in Medicine. 24(11). 2380–2388. 17 indexed citations
11.
12.
Salimi, Ali, Julie Lapointe, & Paul Harasymowycz. (2019). One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities. Ophthalmology and Therapy. 8(4). 563–575. 39 indexed citations
13.
Lapointe, Julie, et al.. (2016). A case study of a national association's actions to advance the integration of occupational justice and human rights in occupational therapy. World Federation of Occupational Therapists Bulletin. 72(1). 51–53. 1 indexed citations
14.
Robert, Marie-Claude, Julie Lapointe, Mona Harissi‐Dagher, et al.. (2015). Evolution of Corneal Transplantation in the Province of Quebec From 2000 to 2011. Cornea. 34(8). 880–887. 15 indexed citations
15.
Stern, Erica B., et al.. (2015). CarFit Canada: Lessons learned from an international collaboration. World Federation of Occupational Therapists Bulletin. 71(1). 22–25. 1 indexed citations
16.
Lapointe, Julie, et al.. (2013). Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?. Familial Cancer. 12(4). 601–610. 9 indexed citations
17.
Lapointe, Julie, et al.. (2012). Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study. Genetics in Medicine. 14(1). 60–68. 9 indexed citations
18.
Lapointe, Julie, et al.. (2012). Life Events may Contribute to Family Communication About Cancer Risk Following BRCA1/2 Testing. Journal of Genetic Counseling. 22(2). 249–257. 14 indexed citations
19.
Lapointe, Julie, Belkacem Abdous, Stéphanie Camden, et al.. (2011). Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibility. Psycho-Oncology. 21(5). 515–523. 5 indexed citations
20.
Lapointe, Julie, Clermont E. Dionne, Chantal Brisson, & Sylvie Montreuil. (2009). Interaction between postural risk factors and job strain on self-reported musculoskeletal symptoms among users of video display units: a three-year prospective study. Scandinavian Journal of Work Environment & Health. 35(2). 134–144. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silke Zachariae Breakdown of academic impact, for papers by Alice Kennedy Breakdown of academic impact, for papers by Daniel A. Bowen Breakdown of academic impact, for papers by Heather Jackson Breakdown of academic impact, for papers by J. Wallace Breakdown of academic impact, for papers by Gabriela Villanueva Breakdown of academic impact, for papers by Anna Yermachenko Breakdown of academic impact, for papers by Ingrid Solano Breakdown of academic impact, for papers by Senthil Rajasekaran Breakdown of academic impact, for papers by Faith A. Birnbaum
Rankless by CCL
2026